Masthead

nForm Blog

Author: Robin Lynn White

Masthead
autoimmune rendering

Autoimmunity

Q&A with Dr. Oliver Brain: Unintended Consequences Create a Unique Opportunity to Study Inflammatory Bowel Disease.

Oliver Brain, MRCP, PhD, is a principal investigator at the University of Oxford, Nuffield Department of Clinical Medicine, and a recent winner of an nCounter® Autoimmune Profiling Panel through a…

Robin Lynn White / June 3, 2019
Spatial Transcriptomics

Digital Spatial Profiling Q&A

Q&A with Dr. Sergio Rutella: Multi-analyte studies in acute myeloid leukemia

Sergio Rutella, M.D., Ph.D. FRCPath is a Professor of Cancer Immunotherapy at the John van Geest Cancer Research Centre at Nottingham Trent University. His research focuses on acute myeloid leukemia…

Robin Lynn White / December 14, 2017
cancer cell rendering

3D Biology™ Technology Q&A

Q&A with Dr. David Coffey, FHCRC: Multi-analyte studies in multiple myeloma and lymphoma

David Coffey, MD, is a physician scientist with the Fred Hutchinson Cancer Research Center in Seattle, Washington. When he’s not treating patients, he’s in the lab researching blood cancers such…

Robin Lynn White / November 16, 2017
Illustration of a doctor looking at different cell structures

3D Biology™ Technology

Getting More from Flow Cytometry

Immunology studies rely on identifying unique cell populations, such as T cells and B cells, and then analyzing these cells to understand the biology of these cells. Studying different types…

Robin Lynn White / October 2, 2017
cancer cell rendering

3D Biology™ Technology Q&A

Multi-Analyte Analysis of Lung Cancer FFPE Samples with 3D Biology™ Technology

NanoString sat down with McGarry Houghton, M.D., Associate Member of the Clinical Research and Human Biology Divisions at Fred Hutch Cancer Research Center, to discuss how his lab is using…

Robin Lynn White / June 1, 2017
Illustration of a doctor looking at different cell structures

3D Biology™ Technology

Researcher Profiles: How NanoString® Grant Program Winners are Utilizing 3D Biology™ Technology

This past February, four grant program applicants were awarded nCounter Vantage 3D™ Assays of their choice to profile 36 samples. NanoString followed up with each of the winners to explore…

Robin Lynn White / May 8, 2017
Checkpoint inhibitors

Digital Spatial Profiling Q&A

Characterizing Severe Autoimmune Toxicities Associated with Checkpoint Inhibitor Therapies

Immune checkpoint inhibitors (ICI) have emerged as powerful tools against cancer but in some cases have caused inflammation of organ systems that contributed to morbidity or mortality in patients. The…

Robin Lynn White / March 31, 2017
Immunology rendering

3D Biology™ Technology Q&A

Monitoring Clinically Actionable Proteins- A Q&A with Gordon Mills, MD Anderson Cancer Center

NanoString sat down with Gordon Mills, M.D., Ph.D., Chair of Systems Biology Department at MD Anderson Cancer Center in Houston and lead developer of The Cancer Proteome Atlas (TCPA), to…

Robin Lynn White / March 20, 2017
illustration of sequencing probes

Hyb & Seq™ Technology

Live sequencing with the Hyb & Seq™ platform at AGBT 2017

“We wanted to make the world’s simplest sequencer,” remarked Joe Beechem, Ph.D., Senior Vice President of R&D at NanoString. Beechem presented the Hyb & Seq platform with live demonstration during…

Robin Lynn White / February 24, 2017